Marques Vidas, M.; López-Sánchez, P.; Sánchez-Briales, P.; López Illazquez, M.V.; Portolés, J.
Efficacy and Safety in a Real-World Study of the New Oral Formulation of Semaglutide in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. J. Clin. Med. 2024, 13, 5166.
https://doi.org/10.3390/jcm13175166
AMA Style
Marques Vidas M, López-Sánchez P, Sánchez-Briales P, López Illazquez MV, Portolés J.
Efficacy and Safety in a Real-World Study of the New Oral Formulation of Semaglutide in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 2024; 13(17):5166.
https://doi.org/10.3390/jcm13175166
Chicago/Turabian Style
Marques Vidas, MarÃa, Paula López-Sánchez, Paula Sánchez-Briales, MarÃa Victoria López Illazquez, and Jose Portolés.
2024. "Efficacy and Safety in a Real-World Study of the New Oral Formulation of Semaglutide in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus" Journal of Clinical Medicine 13, no. 17: 5166.
https://doi.org/10.3390/jcm13175166
APA Style
Marques Vidas, M., López-Sánchez, P., Sánchez-Briales, P., López Illazquez, M. V., & Portolés, J.
(2024). Efficacy and Safety in a Real-World Study of the New Oral Formulation of Semaglutide in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine, 13(17), 5166.
https://doi.org/10.3390/jcm13175166